Start Date
September 30, 2002
Primary Completion Date
June 30, 2003
Study Completion Date
June 30, 2003
Investigational Seasonal Affective Disorder (SAD) Drug
Study Site, New York
Study Site, Staten Island
Study Site, Lawrence
Study Site, Amityville
Study Site, Williamsville
Study Site, Olean
Study Site, Allentown
Study Site, Philadelphia
Study Site, Philadelphia
Study Site, Newark
Study Site, Washington D.C.
Study Site, Washington D.C.
Study Site, Florence
Study Site, Toledo
Study Site, Cleveland
Study Site, Cleveland
Study Site, Lyndhurst
Study Site, Independence
Study Site, Indianapolis
Study Site, Cincinnati
Study SIte, Greenwood
Study Site, Royal Oak
Study Site, Okemos
Study Site, Milwaukee
Study Site, West Allis
Study Site, Middleton
Study Site, Madison
Study Site, Minneapolis
Study Site, Libertyville
Study SIte, Northfield
Study Site, Hoffman Estates
Study Site, Schaumburg
Study SIte, Chicago
Study Site, Chicago
Study Site, Boise
Study Site, Portland
Study Site, Portland
Study Site, Salem
Study Site, Eugene
Study Site, Seattle
Study Site, Homer
Study Site, New Haven
Study Site, Wilmington
Study Site, Wellesley Hills
Study Site, Moorestown
Study Site, Piscataway
Study Site, Lincoln
Study Site, Edmonton
Study Site, Vancouver
Study Site, Miramichi
Study Site, Sydney
Study Site, Markham
Study Site, Mississauga
Study Site, Hull
Lead Sponsor
GlaxoSmithKline
INDUSTRY